SCHEMBL2476185

SCHEMBL2476185

O=C(Nc1ccc(F)cc1)N1CCC(c2ccc(O)cc2O)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.55
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
KMT2A Q03164 6/20 0.53
NPC1 O15118 3/20 0.53
MAPT P10636 2/20 0.53
RAB9A P51151 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.51
TRPV1 Q8NER1 1/20 0.47
CYP1A2 P05177 1/20 0.47
GAA P10253 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 2/20 0.47
NAMPT P43490 1/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474761 0.93 RAB9A (0.60) CA12CA1CA2CA9KMT2A
SCHEMBL2478741 0.88 NPC1 (0.67) KMT2ANPC1MAPTSMN1; SMN2CYP1A2
SCHEMBL2476567 0.88 TSHR (0.56) CA12CA1CA2CA9KMT2A
SCHEMBL2480782 0.88 NPC1 (0.56) CA12CA1CA2CA9NPC1
SCHEMBL16564209 0.82 MMP1 (0.41) CA12CA1CA2CA9NPC1
SCHEMBL2474909 0.82 ALDH1A1 (0.56) KMT2ANPC1SMN1; SMN2MEN1TSHR
SCHEMBL2500299 0.81 ROCK2 (0.49)
SCHEMBL2476685 0.81 TRPV1 (0.56) NPC1MAPTRAB9ASMN1; SMN2TRPV1
SCHEMBL2476936 0.81 NPC1 (0.64) NPC1MAPTRAB9ASMN1; SMN2LMNA
SCHEMBL16564264 0.78 NPC1 (0.39) CA12CA1CA2CA9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373620-A1 NOVEL 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2011-10-12 EP disclosed